ABCA7 rs10423922: What Your Genotype Means
The rs10423922 variant is a genetic marker located in the ABCA7 gene, which plays a crucial role in lipid transport and immune responses in the brain. Large-scale genetic studies have identified this single nucleotide polymorphism (SNP) as a moderate-confidence risk factor for late-onset Alzheimer's disease. While it is associated with an increased statistical risk, it is not a diagnostic marker and cannot predict whether an individual will definitely develop the condition.
What each genotype means
Typical risk profile
This genotype represents the most common configuration for this variant in many populations. Research indicates that individuals with this profile do not carry the specific genetic marker associated with increased susceptibility to late-onset Alzheimer's disease at this location. Please note that Alzheimer's risk is multifactorial, involving many genetic and environmental influences.
This is the most common genotype, found in the majority of individuals across most global populations.
Slightly elevated risk marker
Carrying one copy of the G allele is associated with a statistically higher risk of developing late-onset Alzheimer's disease compared to those without it. This variant is located in the ABCA7 gene, which plays a role in lipid metabolism and brain health. This association is based on population-level data and does not predict an individual outcome.
This genotype is observed in a significant portion of the population, with the G allele frequency typically ranging between 10% and 15%.
Elevated risk marker
Carrying two copies of the G allele is associated with a higher statistical risk for late-onset Alzheimer's disease compared to individuals with the AA or AG genotypes. The ABCA7 gene is involved in critical cellular processes in the brain, and variations here may influence disease susceptibility. This finding reflects population trends and is not a diagnostic indicator for any individual.
This genotype is the least common of the three, occurring in a smaller percentage of the population consistent with the reported minor allele frequency.
What is rs10423922 and the ABCA7 Gene?
The rs10423922 variant is a single nucleotide polymorphism (SNP) located within the ABCA7 gene on chromosome 19. The ABCA7 gene provides instructions for making a protein belonging to the ATP-binding cassette (ABC) transporter family. These proteins are essential for moving various molecules across cellular membranes. In the human brain, the ABCA7 protein is heavily involved in lipid metabolism, particularly the transport of cholesterol and phospholipids. Additionally, emerging research indicates that ABCA7 plays a vital role in the brain's immune defense system, specifically in a process called phagocytosis, where cellular debris and harmful proteins are cleared away. When the ABCA7 gene functions normally, it helps maintain a healthy balance of lipids and assists in clearing amyloid-beta, a protein that can form damaging plaques in the brain. Variations in this gene, such as rs10423922, may subtly alter how efficiently the protein performs these protective tasks, thereby influencing overall brain health and susceptibility to neurodegenerative conditions over a person's lifespan.
The Link to Late-Onset Alzheimer's Disease
Large-scale genome-wide association studies (GWAS) have consistently identified the ABCA7 gene as a significant susceptibility locus for late-onset Alzheimer's disease (LOAD). The rs10423922 variant, in particular, has emerged as a moderate-confidence risk marker through extensive meta-analyses involving thousands of participants. Researchers believe that risk-enhancing variations in ABCA7 may impair the brain's ability to efficiently clear amyloid-beta peptides. Over time, the accumulation of these peptides can lead to the formation of amyloid plaques, a hallmark pathological feature of Alzheimer's disease. Furthermore, dysfunctional ABCA7 may disrupt lipid homeostasis and microglial response, making the brain more vulnerable to neurodegeneration. It is important to note that the evidence linking rs10423922 to Alzheimer's is statistical and population-based. While the association is well-documented across multiple studies, the variant's individual effect size is relatively small compared to more prominent genetic risk factors like APOE. The presence of this variant alone is not enough to cause the disease, highlighting the complex, multifactorial nature of Alzheimer's.
Population Frequency and Ancestry Differences
The frequency of the rs10423922 variant varies significantly across different global populations, a common characteristic of many genetic markers. According to large genomic databases, the minor allele frequency (MAF) for this variant is approximately 10% to 15% in the general population. However, the exact prevalence can fluctuate based on genetic ancestry. Research has shown that ABCA7 variants contribute to Alzheimer's disease pathophysiology across multiple ethnicities, including populations of European, African, and East Asian descent. Interestingly, some studies suggest that ABCA7 variations may carry a stronger effect size in African American cohorts compared to European cohorts, underscoring the importance of diverse genetic research. Because genetic architecture and linkage disequilibrium differ among ancestries, the statistical impact of rs10423922 might not be uniform worldwide. Understanding these population-level differences helps researchers build more accurate, inclusive genetic risk models and highlights why ancestry must always be considered when interpreting genetic associations.
What You Can and Cannot Do With This Information
Discovering that you carry a risk variant like rs10423922 can be concerning, but it is crucial to understand the limitations of this genetic information. This variant is a statistical marker of risk, not a clinical diagnosis. You cannot use this SNP to predict with certainty whether you will develop late-onset Alzheimer's disease. Many individuals who carry the risk allele never develop the condition, while others without it do. Because Alzheimer's disease is influenced by a complex interplay of genetics, environment, and lifestyle, this single genetic data point should be viewed as just one piece of a much larger puzzle. You can use this information as an educational tool to learn more about brain health and the biological mechanisms of aging. However, you should never use it to make medical decisions or alter prescribed treatments. If you are concerned about your cognitive health or family history of Alzheimer's, the best course of action is to discuss your genetic results and risk factors with a qualified healthcare provider or a certified genetic counselor.
How common is this variant?
The minor allele for rs10423922 has a population frequency of approximately 10-15% globally. Its prevalence and exact statistical impact can vary significantly depending on an individual's genetic ancestry, with notable research highlighting its role across European, African, and East Asian populations.
Frequently asked questions
What is the ABCA7 gene?
The ABCA7 gene provides instructions for making a protein that helps transport lipids across cell membranes. In the brain, it plays a vital role in clearing cellular debris and managing amyloid-beta proteins.
Does having the rs10423922 risk allele mean I will get Alzheimer's?
No, the rs10423922 variant is only a moderate statistical risk factor, not a clinical diagnosis. Many people with the risk allele never develop Alzheimer's disease, as the condition is caused by a complex mix of genetic, environmental, and lifestyle factors.
How does ABCA7 compare to the APOE gene?
While both genes are involved in lipid transport and Alzheimer's risk, APOE is generally considered the strongest genetic risk factor for late-onset Alzheimer's in European populations. ABCA7 variants typically have a smaller effect size, though research suggests they may be more prominent in certain ancestries like African American cohorts.
Can I change my genetic risk for Alzheimer's?
You cannot change your DNA, but genetics is only one part of your overall risk profile. Engaging in heart-healthy habits, staying physically and mentally active, and managing blood pressure can help support overall brain health and potentially mitigate some risk.
Should I talk to a doctor about my rs10423922 result?
If you are feeling anxious about your genetic data or have a strong family history of cognitive decline, speaking with a genetic counselor or doctor is highly recommended. They can help contextualize this result within your broader health profile and provide personalized guidance.
Sources & further reading
Educational information only, last refreshed 9/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10423922?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29